# FDA Inspection 1257757 - Antares Pharma, Inc - January 16, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/antares-pharma-inc/8a43dd2a-96c1-4b2f-9c02-dbc22a8ff5f6
Source feed: FDA_Inspections

> FDA Inspection 1257757 for Antares Pharma, Inc on January 16, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257757
- Company Name: Antares Pharma, Inc
- Inspection Date: 2025-01-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1257757 - 2025-01-16](https://www.globalkeysolutions.net/records/fda_inspections/antares-pharma-inc/a7937fcd-171d-4503-8be5-3396181711b9)
- [FDA Inspection 1073695 - 2018-12-04](https://www.globalkeysolutions.net/records/fda_inspections/antares-pharma-inc/cf3dc7da-f90a-4788-bcc7-9ec40e1ebdce)
- [FDA Inspection 963398 - 2016-01-21](https://www.globalkeysolutions.net/records/fda_inspections/antares-pharma-inc/80b98457-90a0-4a7e-b804-62a14a623d99)
- [FDA Inspection 963398 - 2016-01-21](https://www.globalkeysolutions.net/records/fda_inspections/antares-pharma-inc/3573757b-dd1d-4612-9903-b3cd61f76820)
- [FDA Inspection 798055 - 2012-09-06](https://www.globalkeysolutions.net/records/fda_inspections/antares-pharma-inc/dc4de789-dc19-40aa-9c38-03e801b08a0a)

Company: https://www.globalkeysolutions.net/companies/antares-pharma-inc/27f8256c-c1d6-4d41-b448-7fcac44937dc

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c